Finance

Lists
SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
US$ ७.०८
०.००%
(०.००) 1D
अक्टोबर १, १४:५०:२४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHPMY...
Mkt. cap
६६.१९ अरब
Avg. vol.
११६.००
Volume
०.००
52-wk high
US$ ८.२३
52-wk low
US$ ६.४१
Beta
०.५८
Shares outstanding
१८.३८ करोड
No. of employees
४९ हजार
Mkt. cap
६६.१९ अरब
Avg. vol.
११६.००
Volume
०.००
52-wk high
US$ ८.२३
52-wk low
US$ ६.४१
Beta
०.५८
Shares outstanding
१८.३८ करोड
No. of employees
४९ हजार
News stories
From web sources and news partners
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holdings ADR
CEO-
Employees४८.६ हजार
Founded१९९४ जनवरी १८
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७३.४८ अरब
६८.५१ अरब
७५.२६ अरब
७२.२१ अरब
Cost of goods sold
६६.०३ अरब
६०.५५ अरब
६७.१७ अरब
६४.०९ अरब
Cost of revenue
६६.०३ अरब
६०.५५ अरब
६७.१७ अरब
६४.०९ अरब
Research and development expenses
५५.६५ करोड
८२.४५ करोड
४६.८२ करोड
५०.२६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.७० अरब
४.९७ अरब
४.५९ अरब
४.६५ अरब
Operating expense
५.५८ अरब
५.९१ अरब
५.४७ अरब
५.५५ अरब
Total operating expenses
७१.६० अरब
६६.४७ अरब
७२.६३ अरब
६९.६४ अरब
Operating income
१.८८ अरब
२.०४ अरब
२.६३ अरब
२.५७ अरब
Other non operating income
-८.४८ करोड
-६.३७ करोड
-४.७९ करोड
-७४.२६ लाख
EBT including unusual items
१.४८ अरब
१.५२ अरब
२.४२ अरब
३.२१ अरब
EBT excluding unusual items
१.६१ अरब
१.४४ अरब
२.२७ अरब
३.०३ अरब
Income tax expense
४८.५९ करोड
५३.४१ करोड
५६.९१ करोड
७२.०६ करोड
Effective tax rate
३२.८९%
३५.१०%
२३.५२%
२२.४३%
Other operating expenses
१२.९६ करोड
२७.१३ करोड
१३.२२ करोड
१८.६६ करोड
Net income
६८.८२ करोड
५७.७५ करोड
१.४२ अरब
२.०९ अरब
Net profit margin
०.९४%
०.८४%
१.८८%
२.८९%
Earnings per share
-
-
-
-
Interest and investment income
२०.६६ करोड
-
३.८७ करोड
८७.३५ करोड
Interest expense
-३९.३० करोड
-४७.०४ करोड
-३४.७६ करोड
-३५.८४ करोड
Net interest expenses
-१८.६४ करोड
-४७.०४ करोड
-३०.८९ करोड
५१.५१ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
२.२६ अरब
२.५४ अरब
३.१२ अरब
३.०७ अरब
Gain or loss from assets sale
४.०० करोड
-१५.७२ करोड
-
-१७.९७ करोड
AI content may include mistakes. Learn more
Google एपहरू